State Of New Jersey Common Pension Fund D Cerevel Therapeutics Holdings, Inc. Transaction History

State Of New Jersey Common Pension Fund D

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$38.96 - $42.75 $856,068 - $939,345	-21,973 Reduced 32.38%	45,897 $1.88 Million
Q1 2024 May 02, 2024	BUY	$40.88 - $43.27 $2.77 Million - $2.94 Million	67,870 New	67,870 $2.87 Million
Q2 2023 Aug 02, 2023	BUY	$23.9 - $35.38 $1.76 Million - $2.6 Million	73,492 New	73,492 $2.34 Million
Q4 2022 Feb 01, 2023	BUY	$25.35 - $31.96 $111,387 - $140,432	4,394 Added 5.81%	79,963 $2.52 Million
Q3 2022 Oct 28, 2022	BUY	$25.5 - $41.42 $1.93 Million - $3.13 Million	75,569 New	75,569 $2.14 Million

5.01M

3.3K

Ticker CERE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 155,752,000
Description
Cerevel Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, engages in the development of various therapies for neuroscience diseases. It is developing emraclidine, a positive allosteric modulator (PAM) that is in phase 1b clinical trials for the treatment of schizophrenia; and Darigabat, a PAM, which is in Phase 2 proof-of-...

Get notified when there are updates to the investment portfolio of State Of New Jersey Common Pension Fund D, based on Form 13F filings with the SEC.

Stay updated on State Of New Jersey Common Pension Fund D with notifications on news.